Belimumab (Anti-TNFSF13B / BAFF / CD257)
Belimumab (Anti-TNFSF13B / BAFF / CD257) (A2316-GRP)
Products
Description
Belimumab (Anti-TNFSF13B / BAFF / CD257) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research. MW : 144.56 kDa.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2316 |
| Target | CD markers |